Related Experiment Videos
[A metastatic neuroendocrine tumor with exceptional outcome!]
C Agard1, P Guerzider, J Bouillard
1Service de pneumologie, Centre Hospitalier, Saint-Nazaire, France.
Introduction:
Neuroendocrine tumors are rare, with poor prognosis when not or poorly differentiated.
Exegesis:
The authors report the case of a patient who presented with a metastatic poorly differentiated neuroendocrine tumor that was resistant to chemotherapy. The different sites of the carcinoma were lung, pancreas, kidney and lymph nodes. The patient received no treatment and complete spontaneous remission appeared after 21 months. This remission has been lasting for five years.
Conclusion:
It is the first case of spontaneous remission of a metastatic poorly differentiated neuroendocrine tumor. The evolution and classical sites of neuroendocrine tumors are reviewed. Renal metastasis is also unusual. This report illustrates the fact that neuroendocrine tumors are heterogeneous.
Insights
This is the first reported case of spontaneous remission in a patient with metastatic poorly differentiated neuroendocrine tumor. The remission has lasted five years, highlighting the tumor
Area of Science:
- Oncology
- Tumor Biology
- Medical Case Reports
Background:
- Neuroendocrine tumors (NETs) are rare neoplasms.
- Poorly differentiated NETs often have a poor prognosis.
- Metastatic disease indicates advanced cancer stage.
Observation:
- A patient presented with metastatic, chemotherapy-resistant, poorly differentiated neuroendocrine tumor.
- Tumor sites included lung, pancreas, kidney, and lymph nodes.
- No treatment was administered.
Findings:
- Complete spontaneous remission occurred after 21 months.
- The remission has been sustained for five years.
- This represents the first documented case of spontaneous remission for this type of cancer.
Implications:
- This case challenges conventional understanding of neuroendocrine tumor progression.
- It underscores the potential for unexpected recovery in oncology.
- Highlights the heterogeneity of neuroendocrine tumors and the need for further research into spontaneous remission mechanisms.